3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one

C164H161F19N44O21S2 — CID 160790095

About 3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one

3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one (PubChem CID 160790095) has the molecular formula C164H161F19N44O21S2 and a molecular weight of 3509.47 g/mol. Its IUPAC name is 3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one.

Molecular Properties

• Compound Name: 3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one
• PubChem CID: 160790095
• Molecular Formula: C164H161F19N44O21S2
• Molecular Weight: 3509.47 g/mol
• Exact Mass: 3507.20
• IUPAC Name: 3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one
• SMILES: CCC(=O)N1CCN(c2cccc(Cn3nc(-c4nc(-c5ccc(OC(F)(F)F)cc5)no4)nc3C)c2)CC1.Cc1cccc(Cn2nc(-c3nc(-c4ccc(OC(F)(F)F)cc4)no3)nc2C)c1.Cc1nc(-c2nc(-c3ccc(OC(C)(F)F)cc3)no2)nn1Cc1ccc(OCC(C)C)nc1.Cc1nc(-c2nc(-c3ccc(OC(C)(F)F)cc3)no2)nn1Cc1ccnc(OCC(C)C)c1.Cc1nc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1cccc(N2CCCCC2)c1.Cc1nc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1cccc(N2CCN(S(C)(=O)=O)CC2)c1.Cc1nc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1cccc(S(=O)(=O)N2CCN(C)CC2)c1
• InChI: InChI=1S/C26H26F3N7O3.2C24H24F3N7O4S.C24H23F3N6O2.2C23H24F2N6O3.C20H16F3N5O2/c1-3-22(37)35-13-11-34(12-14-35)20-6-4-5-18(15-20)16-36-17(2)30-24(32-36)25-31-23(33-39-25)19-7-9-21(10-8-19)38-26(27,28)29;1-16-28-22(23-29-21(31-38-23)18-6-8-19(9-7-18)37-24(25,26)27)30-34(16)15-17-4-3-5-20(14-17)39(35,36)33-12-10-32(2)11-13-33;1-16-28-22(23-29-21(31-38-23)18-6-8-20(9-7-18)37-24(25,26)27)30-34(16)15-17-4-3-5-19(14-17)32-10-12-33(13-11-32)39(2,35)36;1-16-28-22(23-29-21(31-35-23)18-8-10-20(11-9-18)34-24(25,26)27)30-33(16)15-17-6-5-7-19(14-17)32-12-3-2-4-13-32;1-14(2)13-32-19-10-5-16(11-26-19)12-31-15(3)27-21(29-31)22-28-20(30-34-22)17-6-8-18(9-7-17)33-23(4,24)25;1-14(2)13-32-19-11-16(9-10-26-19)12-31-15(3)27-21(29-31)22-28-20(30-34-22)17-5-7-18(8-6-17)33-23(4,24)25;1-12-4-3-5-14(10-12)11-28-13(2)24-18(26-28)19-25-17(27-30-19)15-6-8-16(9-7-15)29-20(21,22)23/h4-10,15H,3,11-14,16H2,1-2H3;2*3-9,14H,10-13,15H2,1-2H3;5-11,14H,2-4,12-13,15H2,1H3;2*5-11,14H,12-13H2,1-4H3;3-10H,11H2,1-2H3
• InChIKey: SBSKLSJUBSOYMZ-UHFFFAOYSA-N
• XLogP: 30.17
• TPSA: 704.29 Ų
• H-Bond Acceptors: 62
• Rotatable Bonds: 50
• Heavy Atoms: 250
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3509.47
LogP ≤ 5	30.17
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	62

Frequently Asked Questions

What is the IUPAC name of 3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one?

The IUPAC name of 3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one (CID 160790095) is 3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one.

What is the SMILES notation for 3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one?

The canonical SMILES for 3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one is CCC(=O)N1CCN(c2cccc(Cn3nc(-c4nc(-c5ccc(OC(F)(F)F)cc5)no4)nc3C)c2)CC1.Cc1cccc(Cn2nc(-c3nc(-c4ccc(OC(F)(F)F)cc4)no3)nc2C)c1.Cc1nc(-c2nc(-c3ccc(OC(C)(F)F)cc3)no2)nn1Cc1ccc(OCC(C)C)nc1.Cc1nc(-c2nc(-c3ccc(OC(C)(F)F)cc3)no2)nn1Cc1ccnc(OCC(C)C)c1.Cc1nc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1cccc(N2CCCCC2)c1.Cc1nc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1cccc(N2CCN(S(C)(=O)=O)CC2)c1.Cc1nc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1cccc(S(=O)(=O)N2CCN(C)CC2)c1.

What is the InChIKey of 3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one?

The InChIKey is SBSKLSJUBSOYMZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H26F3N7O3.2C24H24F3N7O4S.C24H23F3N6O2.2C23H24F2N6O3.C20H16F3N5O2/c1-3-22(37)35-13-11-34(12-14-35)20-6-4-5-18(15-20)16-36-17(2)30-24(32-36)25-31-23(33-39-25)19-7-9-21(10-8-19)38-26(27,28)29;1-16-28-22(23-29-21(31-38-23)18-6-8-19(9-7-18)37-24(25,26)27)30-34(16)15-17-4-3-5-20(14-17)39(35,36)33-12-10-32(2)11-13-33;1-16-28-22(23-29-21(31-38-23)18-6-8-20(9-7-18)37-24(25,26)27)30-34(16)15-17-4-3-5-19(14-17)32-10-12-33(13-11-32)39(2,35)36;1-16-28-22(23-29-21(31-35-23)18-8-10-20(11-9-18)34-24(25,26)27)30-33(16)15-17-6-5-7-19(14-17)32-12-3-2-4-13-32;1-14(2)13-32-19-10-5-16(11-26-19)12-31-15(3)27-21(29-31)22-28-20(30-34-22)17-6-8-18(9-7-17)33-23(4,24)25;1-14(2)13-32-19-11-16(9-10-26-19)12-31-15(3)27-21(29-31)22-28-20(30-34-22)17-5-7-18(8-6-17)33-23(4,24)25;1-12-4-3-5-14(10-12)11-28-13(2)24-18(26-28)19-25-17(27-30-19)15-6-8-16(9-7-15)29-20(21,22)23/h4-10,15H,3,11-14,16H2,1-2H3;2*3-9,14H,10-13,15H2,1-2H3;5-11,14H,2-4,12-13,15H2,1H3;2*5-11,14H,12-13H2,1-4H3;3-10H,11H2,1-2H3.

What are the key properties of 3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one?

3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one has a molecular weight of 3509.47 g/mol, XLogP of 30.17, 50 rotatable bonds, 0 hydrogen bond donors, and 62 hydrogen bond acceptors.

Where does this data come from?

All data for 3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[2-(2-methylpropoxy)-4-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;3-[4-(1,1-difluoroethoxy)phenyl]-5-[5-methyl-1-[[6-(2-methylpropoxy)-3-pyridinyl]methyl]-1,2,4-triazol-3-yl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-methylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylpiperazin-1-yl)sulfonylphenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;5-[5-methyl-1-[(3-piperidin-1-ylphenyl)methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole;1-[4-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1,2,4-triazol-1-yl]methyl]phenyl]piperazin-1-yl]propan-1-one is sourced from PubChem (CID 160790095), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).